Skip to main content
SpringerLink
Log in

Resistance to cytostatic drugs at the cellular level

  • Review
  • Resistance, Cytostatic Drugs, Cellular Level
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Akiyama S, Ikezaki K, Kuramochi H, Takahashi K, Kuwano M (1981) Bleomycin-resistant cells contain increased bleomycin-hydrolase activities. Biochem Biophys Res Commun 101: 55

    Google Scholar 

  2. Andrews PA, Murphy MP, Howell SB (1989) Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cells. Eur J Cancer Clin Oncol 25: 619

    Google Scholar 

  3. Arceci RJ, Croop JM, Horwitz S, Housman D (1988) The gene encording multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci USA 85: 4350

    Google Scholar 

  4. Babson JR, Abell NS, Reed DJ (1981) Protective role of the glutathione redox cycle against Adriamycin-mediated toxicity in isolated hepatocytes. Biochem Pharmacol 30: 2299

    Google Scholar 

  5. Bakka A, Endresen L, Johnsen ABS, Edminson PD, Rugstad HE (1981) Resistance againstcis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein. Toxicol Appl Pharmacol 61: 215

    Google Scholar 

  6. Baker RM, Ling V (1978) Membrane mutants of mammalian cells in culture. In: Korn ED (ed) Methods in membrane biology, vol 9. Plenum, New York, pp 337–384

    Google Scholar 

  7. Banerjee SP, Snyder SH (1973) Methylhydrofolic acid mediatesN-andO-methylation of biogenic amines. Science 182: 74

    Google Scholar 

  8. Barrows LR, Borchers AH, Paxton MB (1987) Transfectant CHO cells expressing O6-alkylguanine-DNA-alkyltransferase display increased resistance to DNA damage other than O6-guanine alkylation. Carcinogenesis 8: 1853

    Google Scholar 

  9. Basking F, Carlin SC, Kraus P, Friedkin M, Rosenberg RN (1975) Experimental chemotherapy of neuroblastoma: II. Increased thymidylate synthetase in a 5-fluorodeoxyuridine-resistant variant of mouse neuroblastoma. Mol Pharmacol 11: 105

    Google Scholar 

  10. Batist G, Muys JM de, Cowan KH, Myers CE (1986) Purification and characterisation of a novel glutathione-S-transferase in multidrug resistant human breast cancer cells. Proc Am Assoc Cancer Res 27: 270

    Google Scholar 

  11. Beck WT, Cirtain MC (1982) Continued expression of vinca-alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin or pronase. Cancer Res 42: 184

    Google Scholar 

  12. Beck WT, Mueller TJ, Tanzer KR (1979) Altered surface membrane glycoproteins in vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res 39: 2070

    Google Scholar 

  13. Beck WT, Cirtain MC, Look AT, Asmun RA (1986) Reversal of vinca-alkaloid resistance but not multiple drug-resistance in human leukemic cells by verapamil. Cancer Res 46: 778

    Google Scholar 

  14. Bedford P, Fox BW (1982) Repair of DNA interstrand crosslinks after busulphan: a possible mode of resistance. Cancer Chemother Pharmacol 8: 3

    Google Scholar 

  15. Bedford P, Fichtinger-Schepman AMJ, Masters JRW, Hill BR (1987) Immunochemical detection of cis-platin-DNA adducts in human testicular and bladder tumour cell lines. Br J Cancer 56: 191

    Google Scholar 

  16. Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, Knutsen T, McKoy WM, Young RC, Ozols RF (1987) Characterisation of acis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res 47: 414

    Google Scholar 

  17. Bell DR, Gerlach JH, Kartner N, Buick RN, Ling V (1985) Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J Clin Oncol 3: 311

    Google Scholar 

  18. Bertino JR (1974) Folate antagonists, antineoplastic and immunosuppressive agents. In: Sartorelli AC, Johns DG (eds) Handbook of experimental pharmacology, vol 38, part 2. Springer, New York Berlin Heidelberg, p 468

    Google Scholar 

  19. Biedler JL, Spengler BA (1976) Metaphase chromosome anomaly: association with drug resistance and cell-specific products. Science 191: 185

    Google Scholar 

  20. Bohr VA, Phillips DH, Hanawalt PC (1987) Heterogenous DNA damage and repair in the mammalian genome. Cancer Res 47: 6426

    Google Scholar 

  21. Bouchard J, Bastow KF, Starnes MC, Prabhu R, Cheng Y-C (1985) Characterization of dihydrofolate reductase-related DNA and RNA from human KB cell subclones containing different amounts of the enzyme. Cancer Res 45: 1717

    Google Scholar 

  22. Bradley G, Juranka PF, Ling V (1988) Mechanisms of multidrug resistance. Biochim Biophys Acta 948: 87

    Google Scholar 

  23. Brockman RW (1963) Mechanisms of resistance to the anticancer agents. Adv Cancer Res 7: 129

    Google Scholar 

  24. Browman PG, Csullog GW (1981) Modification of in vitro methotrexate antitumor effect in L1210 leukemia by induced impairment of purine salvage. Biochem Pharmacol 30: 869

    Google Scholar 

  25. Brown PC, Beverly SM, Schimke RT (1981) Relationship of amplified dihydrofolate reductase genes to double minute chromosomes in unstably resistant mouse fibroblast genes. Mol Cell Biol 1: 1077

    Google Scholar 

  26. Bungo M, Fujiwara Y, Kasahare K, Nakagawa K, Ohe Y, Sasaki Y, Irino S, Saijno N (1990) Decreased accumulation as a mechanism of resistance tocis-diamminedichloroplatinum(II) in human nonsmall lung cancer cell lines: relation to DNA damage and repair. Cancer Res 50: 2549

    Google Scholar 

  27. Cabral F, Sobel ME, Gottesman MM (1980) CHO mutants resistant to colchicine, colcemid or grieseofulvin have altered β-tubulin. Cell 20: 29

    Google Scholar 

  28. Carman MD, Schornagel JH, Rivest RS, Srimatkandada S, Portlock CS, Duffy T, Bertino JR (1984) Resistance to methotrexate due to gene amplification in a patient with acute leukemia. J Clin Oncol 2: 16

    Google Scholar 

  29. Chatterjee M, Harris AL (1990) Reversal of multidrug resistance by verapamil and modulation by alpha-1 acid glycoprotein in wildtype and multidrug-resistant Chinese hamster ovary cell lines. Cancer Res 50: 2818

    Google Scholar 

  30. Crathorn AR, Roberts JJ (1966) Mechanism of the cytotoxic action of alkylating agents in mammalian cells and for the removal of alkylated groups from deoxyribonucleic acid. Nature 211: 150

    Google Scholar 

  31. Centen M (1985) Mechanisms regulating cell resistance to Adriamycin. Biochem Pharmacol 34: 1471

    Google Scholar 

  32. Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB (1986) Internal duplication and homology to bacterial transport proteins in the mdr 1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47: 381

    Google Scholar 

  33. Chou TH, Kessel D (1981) Effects of tunicamycin on anthracycline resistance in P 388 murine leukemia cells. Biochem Pharmacol 30: 3134

    Google Scholar 

  34. Chou TH, Yost C (1985) Adriamycin resistance in murine leukemia P388 cells and increased DNA repair. Proc Am Assoc Cancer Res 26: 217

    Google Scholar 

  35. Connors T (1966) Protection against the toxicity of alkylating agents by thiols: the mechanism of protection and its relevance to cancer chemotherapy. Eur J Cancer 2: 293

    Google Scholar 

  36. Cornwell MM, Gottesman MM, Pastan I (1986) Increased vinblasting binding to membrane vesicles from multidrug-resistant KB cells. J Biol Chem 261: 7921

    Google Scholar 

  37. Cornwell MM, Safa AR, Felsted RL, Gottesman MM, Pastan I (1986) Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150–170 kDa protein detected by photoaffinity labelling. Proc Natl Acad Sci USA 83: 3847

    Google Scholar 

  38. Cornwell MM, Pastan I, Gottesman MM (1987) Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 262: 2166

    Google Scholar 

  39. Cowan KH, Goldsmith ME, Levine RM, Aitken SC, Douglass E, Clendeninn N, Nienhuis AW, Lippman ME (1982) Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate-resistant human breast cancer cells. J Biol Chem 257: 15079

    Google Scholar 

  40. Crouse GF, Simonson CC, McEwan RN, Schimke RT (1982) Structure of amplified normal and variant dihydrofolate reductase genes in mouse sarcoma S 180 cells. J Biol Chem 257: 7887

    Google Scholar 

  41. Curt GA, Carney DN, Cowan KH, Jolivet J, Bailey BD, Drake JC, Kao-Shan CS, Minna JD, Chabner BA (1983) Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomes. N Engl J Med 308: 199

    Google Scholar 

  42. Curt GA, Clendeninn NJ, Chabner BA (1984) Drug resistance in cancer. Cancer Treat Rep 68: 87

    Google Scholar 

  43. Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Durie BGM, Taylor CW, Miller TP, Salmon SE (1989) Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of a P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 7: 415

    Google Scholar 

  44. Danks MK, Schmidt CA, Cirtain MC, Suttle DP, Beck WT (1988) Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26. Biochemistry 27: 8861

    Google Scholar 

  45. Dano K (1973) Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochem Biophys Acta 323: 466

    Google Scholar 

  46. Davidson JD, Winter TS (1964) Purine nucleotide phosphorylases in 6-mercaptopurine-sensitive and resistant human leukemias. Cancer Res 24: 261

    Google Scholar 

  47. Debenham PG, Kartner M, Siminovitch L, Riordan JR, Ling V (1982) DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression. Mol Cell Biol 2: 881

    Google Scholar 

  48. De Bruijn MHL, Van der Bliek AM, Biedler JL, Borst P (1986) Amplification and disproportionate expression of five genes in three multidrug-resistant Chinese hamster lung cell lines. Mol Cell Biol 6: 4717

    Google Scholar 

  49. Dedhar S, Goldie JH (1983) Overproduction of two antigenically distinct forms of dihydrofolate reductase in a highly methotrexateresistant mouse leukemia cell line. Cancer Res 43: 4863

    Google Scholar 

  50. Dedhar S, Goldie JH (1985) Methotrexate resistant human promyelocytic leukemia (HL-60) cells express a dihydrofolate reductase with altered properties associated with increased enzyme activity. Biochem Biophys Res Commun 29: 536

    Google Scholar 

  51. Dedhar S, Hartley D, Goldie JH (1985) Increased dihydrofolate reductase activity in methotrexate-resistant human promyelocytic leukemia (HL-60) cells. Biochem J 225: 609

    Google Scholar 

  52. Deffie AM, Batra JK, Goldenberg GJ (1989) Direct correlation between DNA topoisomerase II activity and cytotoxicity in Adriamycin-sensistive and-resistant P388 leukemia cell lines. Cancer Res 49: 58

    Google Scholar 

  53. Dolan ME, Norbeck L, Clyde C, Hora NK, Erickson LC, Peggy AE (1989) Expression of mammalian O6-alkylguanine-DNA alkyltransferase in a cell line sensitive to alkylating agents. Carcinogenesis 10: 1613

    Google Scholar 

  54. De Saint-Vincent BR, Buttin G (1979) Studies on 1-β-d-arabinofuranosylcytosine-resistant mutants of Chinese hamster fibroblasts. Eur J Biochem 37: 481

    Google Scholar 

  55. De Saint-Vincent BR, Buttin G (1979) Studies on 1-β-d-arabinofuranosylcytosine-resistant mutants of Chinese hamster fibroblasts: joint resistance to arabinofuranosylcytosine and to excess thymidine—a semidominant manifestation of deoxycytidine triphosphate pool expansion. Somat Cell Genet 5: 67

    Google Scholar 

  56. Dijt FJ, Fichtinger-Schepman AMJ, Berends F, Reedijk J (1988) Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts. Cancer Res 48: 6058

    Google Scholar 

  57. Dolnick BJ, Berenson RJ, Bertino JR, Kaufman RJ, Nunberg JH, Schimke RT (1979) Correlation of dihydrofolate reductase elevation with gene amplification in a homogeneously staining chromosomal region in L5178Y cells. J Cell Biol 83: 394

    Google Scholar 

  58. Domin BA, Grill SP, Cheng Y (1983) Establishment of dihydrofolate reductase-increased human cell lines and relationship between dihydrofolate reductase levels and gene copy. Cancer Res 43: 2155

    Google Scholar 

  59. Doroshow JH, Locker GY, Ifrim I, Myers CE (1981) Prevention of doxorubicin cardiac toxicity in the mouse byN-acetylcysteine. J Clin Invest 68: 1053

    Google Scholar 

  60. Drahovsky D, Kreis W (1970) Studies on drug resistance: II. Kinase patterns in P815 neoplasms sensitive and resistant to 1-arabinofuranosylcytosine. Biochem Pharmacol 19: 940

    Google Scholar 

  61. Eastman A (1987) Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordiantion complexes. Chem Biol Interact 61: 241

    Google Scholar 

  62. Eastman A, Bresnick E (1981) Studies on the resistance of a murine leukemia L1210 cell line tocis-diamminedichloroplatinum(II). Biochem Pharmacol 30: 2721

    Google Scholar 

  63. Eastman A, Schulte N, Sheibani N, Sorensen CM (1987) Mechanisms of resistance to platinum drugs. In: Nicolini M (ed) Platinum and other metal coordination compounds in cancer chemotherapy. Martinus Nijhoff, Dordrecht, pp 178–196

    Google Scholar 

  64. Endicott JA, Juranka PF, Sarangi F, Gerlach JH, Deuchars KL, Ling V (1987) Simultaneous expression of two P-glycoprotein genes in drug-sensitive Chinese hamster ovary cells. Mol Cell Biol 7: 4075

    Google Scholar 

  65. Endresen L, Bakka A, Rugstad HE (1983) Increased resistance to chlorambucil in cultured cells with a high concentration of cytoplasmic metallothionein. Cancer Res 43:2918

    Google Scholar 

  66. Endresen L, Schjerven L, Rugstad HE (1984) Tumours from a cell strain with a high content of metallothionein show enhanced resistance againstcis-dichlorodiammineplatinum. Acta Pharmacol Toxicol 55:183

    Google Scholar 

  67. Ferguson PJ, Fischer MH, Stephenson J, Li D, Zhou B, Cheng Y (1988) Combined modalities of resistance in etoposide-resistant human KB cell lines. Cancer Res 48:5956

    Google Scholar 

  68. Fichtinger-Schepman AMJ, Vendrik CPJ, Van Dijk-Knijnenburg WCM, De Jong WH, Van der Minnen ACE, Claessen AM, Van der Velde-Visser SD, De Groot G, Wubs KL, Steerenberg PA, Schornagel JH, Berends F (1989) Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or-resistant immunoglobulin M immunocytoma. Cancer Res 49:2862

    Google Scholar 

  69. Fine RL, Finkel MS, Curt GA, Schepartz SA, Chabner BA (1984) Reversal of Adriamycin resistance in CHO cells by nitrendipine is not mediated by binding to calcium channel receptors. Proc Am Assoc Cancer Res 25:14

    Google Scholar 

  70. Fine RL, Patel J, Allegra CJ, Curt GA, Cowan KH, Ozols RF, Lippman ME, McDevitt R, Chabner BA (1985) Increased phosphorylation of a 20,000 M. W. protein in pleiotropic drug-resistant MCF human breast cancer lines. Proc Am Assoc Cancer Res 26:345

    Google Scholar 

  71. Fine RL, Carmichael J, Patel J, Carney DN, Gazdar A, Curt GA, Minna JD, Chabner BA (1986) Increased phosphorylation of a 20-kDa protein is associated with pleiotropic drug resistance in human small-cell lung cancer lines. Proc Am Soc Clin Oncol 5:17

    Google Scholar 

  72. Fine RL, Patel J, Chabner BA (1988) Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci USA 85:582

    Google Scholar 

  73. Flinthoff WF, Essani K (1980) Methotrexate-resistant Chinese hamster ovary cells contain a dihydrofolate reductase with an altered affinity for methotrexate. Biochemistry 19:4321

    Google Scholar 

  74. Fojo AT, Akiyama SI, Gottesman MM, Pastan I (1985) Reduced drug accumulation in multiple drug-resistant human KB carcinoma cell lines. Cancer Res 45:3002

    Google Scholar 

  75. Fojo AT, Hamilton TC, Young RC, Ozols RF (1987) Multidrug resistance in ovarian cancer. Cancer 60:2075

    Google Scholar 

  76. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Patan I (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84:265

    Google Scholar 

  77. Frei E, Rosowsky A, Wright JE, Cucchi CA, Lippke JA, Ervin TJ, Jolivet J, Haseltine WA (1984) Development of methotrexate resistance in a human squamous-cell carcinoma of the head and neck in culture. Proc Natl Acad Sci USA 81:2873

    Google Scholar 

  78. Galivan J (1979) Transport and metabolism of methotrexate in normal and resistant cultured rat hepatoma cells. Cancer Res 39:735

    Google Scholar 

  79. Garman D, Center MS (1982) Alterations in cell surface membranes in Chinese hamster lung cells resistant to Adriamycin. Biochem Biophys Res Commun 105:157

    Google Scholar 

  80. Gerlach JH, Endicott JA, Juranka PF, Henderson G, Sarangi F, Deuchars KL, Ling V (1986) Homology between P-glycoprotein and bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature 324:485

    Google Scholar 

  81. Gerlach JH, Bell DR, Karakousis C, Slocum HK, Kartner N, Rustum YM, Ling V, Baker RM (1987) P-glycoprotein in human sarcoma: evidence for multidrug resistance. J Clin Oncol 5:1452

    Google Scholar 

  82. Gessner T, Vaughan LA, Beehler BC, Bartels CJ, Baker RM (1990) Elevated pentose cycle and glucuronyltransferase in daunorubicin-resistant P388 cells. Cancer Res 50:3921

    Google Scholar 

  83. Glisson B, Gupta R, Smallwood-Kentro S, Ross W (1986) Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity. Cancer Res 46:1934

    Google Scholar 

  84. Glisson B, Gupta R, Hodges P, Ross W (1986) Cross-resistance to intercalating agents in a epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target. Cancer Res 46:1939

    Google Scholar 

  85. Goldenberg GJ, Vanstone CL, Israels LG, Ilse D, Bihler I (1970) Evidence for a transport carrier of nitrogen mustard in nitrogen mustard-sensitive and-resistant L5178Y lymphoblasts. Cancer Res 30:2285

    Google Scholar 

  86. Goldenberg GJ, Vanstone CL, Bihler I (1971) Transport of nitrogen mustard on the transport-carrier for choline in L5178Y lymphoblasts. Science 172:1148

    Google Scholar 

  87. Goldie JH, Coldman AJ (1979) A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63:1727

    Google Scholar 

  88. Goldman ID (1982) Pharmacokinetics of antineoplastic agents at the cellular level. In: Chabner BA (ed) Pharmacologic principles of cancer treatment. W. B. Saunders, Philadelphia, pp 15–44

    Google Scholar 

  89. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pastan I (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81:116

    Google Scholar 

  90. Griffin DW (1982) Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologies, potent inhibitors of glutathione synthesis. J Biol Chem 257:13704

    Google Scholar 

  91. Gros P, Croop JM, Roninson IB, Varshavsky A, Housman DE (1986) Isolation and characterisation of DNA sequences amplified in multidrug-resistant hamster cells. Proc Natl Acad Sci USA 83:337

    Google Scholar 

  92. Gros P, Croop JM, Housman DE (1986) Mammalian multidrug-resistant gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47:371

    Google Scholar 

  93. Gros P, Neriah YB, Croop JM, Housman DE (1986) Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323:728

    Google Scholar 

  94. Gupta RS, Ho TKW, Moffat MRK, Gupta R (1982) Podophyllotoxin-resistant mutants of Chinese hamster ovary cells: alteration of a microtubule-associated protein. J Biol Chem 257:1071

    Google Scholar 

  95. Haber DA, Beverley SM, Kiely ML, Schimke RT (1981) Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblasts. J Biol Chem 256:9501

    Google Scholar 

  96. Hänggi UJ, Littlefield JW (1974) Isolation and characterisation of the multiple forms of dihydrofolate reductase from methotrexate-resistant hamster cells. J Biol Chem 249:1390

    Google Scholar 

  97. Hamilton TC, Winkel MA, Louie KG, Batist G, Behrens BC, Tsuruo T, Grotzinger KR, McKoy WM, Young RC, Ozols RF (1985) Augmentation of Adriamycin, melphalan and cisplatin cytotoxicity in drug-resistant ovarian cancer cell lines by buthionine sulfoximine-mediated glutathione depletion. Biochem Pharmacol 34:2853

    Google Scholar 

  98. Hamilton TC, Lai G-M, Rothenberg ML, Fojo A, Young RC, Ozols RF (1989) Mechanisms of resistance to alkylating agents and cisplatin. In: Ozols RF (ed) Cancer treatment and research: drug resistance. Martinus Nijhoff, Boston, pp 151–169

    Google Scholar 

  99. Hill BT, Bailey BD, White JC, Goldman ID (1979) Characteristics of transport of 4-amino antifolates and folate compounds by two lines of L5178Y lymphoblasts, one with impaired transport of methotrexate. Cancer Res 39:2440

    Google Scholar 

  100. Hill BT, Dedhar S, Goldie JH (1982) Evidence that at “high” extracellular methotrexate concentrations the transport barrier is unlikely to be an important mechanism of drug resistance. Biochem Pharmacol 31:263

    Google Scholar 

  101. Hitchins PN, Harman DH, Davey RA, Bell DR (1988) Identification of a multidrug resistance-associated antigen (P-glycoprotein) in normal human tissues. Eur J Cancer Clin Oncol 24:449

    Google Scholar 

  102. Horns RC, Dower WJ, Schimke RT (1984) Gene amplification in a leukemic patient treated with methotrexate. J Clin Oncol 2:2

    Google Scholar 

  103. Houghton JA, Houghton PJ, Hazelton BJ, Douglass EC (1985) In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered β-tubulins. Cancer Res 45:2706

    Google Scholar 

  104. Hromas RA, North JA, Burns CP (1986) Cis-platinum uptake in L1210 leukemia cells resistant and sensitive to the drug. Proc Am Assoc Cancer Res 27:263

    Google Scholar 

  105. Hromas RA, Andrews PA, Murphy MP, Burns CP (1987) Glutathione depletion reverses cisplatin resistance in murine L1210 leukemia cells. Cancer Lett 34:9

    Google Scholar 

  106. Huang Yang C-P, Goei DePinho S, Greenberger LM, Arceci RJ, Band Horwitz S (1989) Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. J Biol Chem 264:782

    Google Scholar 

  107. Ikeda H, Nakano G, Nagashima K, Sakamoto K, Harasawa N, Kitamura T, Nakamura T, Nagamachi Y (1987) Verapamil enhancement of the antitumor effect ofcis-diamminedichloroplatinum(II) in nude mouse-grown neuroblastoma. Cancer Res 47:231

    Google Scholar 

  108. Inaba M, Sakuray Y (1979) Enhanced efflux of actinomycin D, vincristine and vinblastine in an Adriamycin-resistant subline of P388 leukemia. Cancer Lett 8:111

    Google Scholar 

  109. Inaba M, Kobayashi H, Sakuray Y, Johnson RK (1979) Active efflux of daunomucin and Adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res 39:2200

    Google Scholar 

  110. Inaba M, Fujikura R, Sakuray Y (1981) Active efflux common to vincristine and daunorubicin in vincristine-resistant P 388 leukemia. Biochem Pharmacol 30:1863

    Google Scholar 

  111. Inaba M, Fujikura R, Tsukagoshi S, Sakuray Y (1981) Restored in vitro sensitivity of Adriamycin- and vincristine-resistant P 388 leukemia with reserpine. Biochem Pharmacol 30:2191

    Google Scholar 

  112. Jackson RC, Niethammer D (1979) Acquired methotrexate resistance in lymphoblasts resulting from altered kinetic properties of dihydrofolate reductase. Eur J Cancer 13:567

    Google Scholar 

  113. Jansen G, Westerhof GR, Kathmann I, Rademaker BC, Rijksen G, Schornagel JH (1989) Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance. Cancer Res 49:2455

    Google Scholar 

  114. Jiang B-Z, Bank BB, Hsiang Y-H, Shen T, Potmesil M, Silber R (1989) Lack of drug-induced DNA cross-links in chlorambucil-resistant Chinese hamster ovary cells. Cancer Res 49:5514

    Google Scholar 

  115. Johns DG, Bertino JR (1973) Folate antagonists. In: Holland JF, Frei E III (eds) Cancer medicine. Lea and Febiger, Philadelphia, p 739

    Google Scholar 

  116. Jolivet J, Schilsky RL, Bailey BD, Drake JC, Chabner BA (1982) Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells. J Clin Invest 70:351

    Google Scholar 

  117. Jongsma APM, Spengler BA, Van der Bliek AM, Borst P, Biedler JL (1987) Chromosomal localisation of three genes coamplified in the multidrug-resistant CHR-C5 Chinese hamster ovary cell line. Cancer Res 47:2875

    Google Scholar 

  118. Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese ovary cell mutants. Biochim Biophys Acta 455:152

    Google Scholar 

  119. Kano Y, Ohnuma T, Holland JF (1986) Folate requirements of methotrexate-resistant human acute lymphoblastic leukemia cell lines. Blood 68:586

    Google Scholar 

  120. Kartner N, Shales M, Riordan JR, Ling V (1983) Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell surface P-glycoprotein. Cancer Res 43:4413

    Google Scholar 

  121. Kartner N, Riordan JR, Ling V (1983) Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221:1285

    Google Scholar 

  122. Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T, Saijo N (1991) Metallothionein correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res 51:3237

    Google Scholar 

  123. Kasbekar DK, Greenberg DM (1963) Studies on tumor resistance to 5-fluorouracil. Cancer Res 23:818

    Google Scholar 

  124. Kaufman ER (1984) Resistance to 5-fluorouracil associated with increased cytidine triphosphate levels in V79 Chinese hamster cells. Cancer Res 44:3371

    Google Scholar 

  125. Kaufman RJ, Brown PC, Schimke RT (1979) Amplified dihydrofolate reductase genes in unstably methotrexate-resistant cells are associated with double minute chromosomes. Proc Natl Acad Sci 76:5669

    Google Scholar 

  126. Kaufman RJ, Brown PC, Schimke RT (1981) Loss and stabilization of amplified dihydrofolate reductase genes in mouse sarcoma S180 cell lines. Mol Cell Biol 12:1084

    Google Scholar 

  127. Kaye SB, Boden JA (1980) Cross-resistance between actinomycin D, Adriamycin and vincristine in a murine solid tumour in vivo. Biochem Pharmacol 29:1081

    Google Scholar 

  128. Keats RA, Sarangi F, Ling V (1981) Structural and functional alterations in microtubule protein from Chinese hamster ovary cell mutants. Proc Natl Acad Sci USA 78:5639

    Google Scholar 

  129. Kees UR, Ford J, Dawson VM, Piall E, Aherne GW (1989) Development of resistance to 1-β-d-arabinofuranosylcytosine after high-dose treatment in childhood lymphoblastic leukemia: analysis of resistance mechanism in established cell lines. Cancer Res 49:3015

    Google Scholar 

  130. Kessel D, Wilberding C (1984) Mode of action of calcium antagonists which alter anthracycline resistance. Biochem Pharmacol 33:1157

    Google Scholar 

  131. Kessel D, Wilberding C (1985) Anthracycline resistance in P 388 murine leukemia and its circumvention by calcium antagonists. Cancer Res 45:1687

    Google Scholar 

  132. Kessel D, Wodinsky I (1970) Thymidine kinase as a determinant of the response to 5-fluoro-2′-deoxyuridine in transplantable murine leukemias. Mol Pharmacol 6:251

    Google Scholar 

  133. Kikuchi Y, Oomori K, Kirawa I, Hirata J, Kita T, Miyauchi M (1987) Enhancement of antineoplastic effects of cisplatin by calmodulin antagonists in nude mice bearing human ovarian carcinoma. Cancer Res 47:6459

    Google Scholar 

  134. Koren R, Shohami E, Yeroushalmi S (1979) A kinetic analysis of the uptake of cytosine-β-d-arabinoside by rat B-77 cells. Eur J Biochem 95:333

    Google Scholar 

  135. Kuwazuru Y, Yoshimura A, Hanada S, Utsunumiya A, Makino T, Ishibashi K, Kodama M, Iwahashi M, Arima T, Akiyama S-I (1990) Expression of the multidrug transporter, P-glycoprotein, in adult leukemia cells and correlation to clinical drug resistance. Cancer 66:868

    Google Scholar 

  136. Lai G-M, Ozols RF, Young RC, Hamilton TC (1989) Effect of glutathione on DNA repair in cisplatin resistant human ovarian cancer cell lines. J Natl Cancer Inst 81:535

    Google Scholar 

  137. Laskin JD, Envans RM, Slocum HK, Burke D, Hakala M (1979) Basis for natural variation in sensitivity to 5-fluorouracil in mouse and human cells in culture. Cancer Res 39:383

    Google Scholar 

  138. Lee MH, Huang YM, Sartorelli AC (1978) Alkaline phosphatase activities of 6-thiopurine-sensitive and-resistant sublines of sarcoma 180. Cancer Res 38:2413

    Google Scholar 

  139. Lee MH, Huang YM, Sartorelli AC (1978) Immunological studies on alkaline phosphatases of 6-thiopurine-sensitive and-resistant sublines of sarcoma 180. Cancer Res 38:2419

    Google Scholar 

  140. Ling V (1975) Drug resistance and membrane alteration in mutants of mammalian cells. Can J Genet Cytol 17:503

    Google Scholar 

  141. Ling V (1982) Genetic basis of drug resistance in mammalian cells. In: Brachovsky N, Goldie JH (eds) Drug and hormone resistance in neoplasia, vol I. CRC Press, Miami, pp 1–19

    Google Scholar 

  142. Ling V, Baker RM (1978) Dominance of colchicine resistance in hybrid CHO cells. Somat Cell Genet 42:193

    Google Scholar 

  143. Ling V, Thompson LH (1974) Reduced permeability in CHO cells as mechanism of resistance to colchicine. J Cell Physiol 83:103

    Google Scholar 

  144. Ling V, Aubin JE, Sarangi F (1979) Mutants of Chinese hamster ovary (CHO) cells with altered colcemid-binding affinity. Cell 18:423

    Google Scholar 

  145. Ling V, Kartner N, Sudo T, Siminovitch L, Riordan JR (1983) Multidrug resistant phenotype in Chinese hamster ovary cells. Cancer Treat Rep 67:869

    Google Scholar 

  146. Louie KG, Behrens BC, Kinsella TJ, Hamilton TC, Grotzinger KR, McKoy WM, Winker MA, Young RC, Ozols RF (1985) Radiation survival parameters of antineoplatic drug-sensitive and-resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. Cancer Res 45:2110

    Google Scholar 

  147. Ma DFF, Davey RA, Harman DH, Isbister JP, Scurr RD, Makertich SM, Dowden G, Bell DR (1987) Detection of a multidrug resistance phenotype in acute non-lymphoblastic leukemia. Lancet I:135

    Google Scholar 

  148. Masuda H, Ozols RF, Lai G-M, Fojo A, Rothenberg M, Hamilton TC (1988) Increased DNA repair as a mechanism of acquired resistance tocis-diamminedichloroplatinum(II) in human ovarian cancer cell lines. Cancer Res 48:5713

    Google Scholar 

  149. Maurice PA, Lederrey C (1977) Increased sensitivity of chronic lymphocytic leukemia lymphocytes to alkylating agents due to a deficient DNA repair mechanism. Eur J Cancer 13:1033

    Google Scholar 

  150. McCormick JL, Susten SS, Freisheim JH (1981) Characterization of the methotrexate transport defect in a resistant L1210 lymphoma cell line. Arch Biochem Biophys 212:311

    Google Scholar 

  151. Melera PW, Lewis JA, Biedler JL, Hession CA (1980) Antifolate-resistant Chinese hamster cells: evidence for dihydrofolate reductase gene amplification among independantly derived sublines overproducing different dihydrofolate reductases. J Biol Chem 255:7024

    Google Scholar 

  152. Melera PW, Hession CA, David JP, Scotto KW, Biedler JL, Meyers MB, Shanske S (1982) Antifolate-resistant Chinese hamster cells: mRNA directed overproduction of multiple dihydrofolate reductases from a series of independantly derived sublines containing amplified dihydrofolate reductase genes. J Biol Chem 257:12939

    Google Scholar 

  153. Meyn RE, Jenkins SF, Thompson LH (1982) Defective removal of DNA cross-links in a repair-deficient mutant of Chinese hamster cells. Cancer Res 42:3106

    Google Scholar 

  154. Micetich K, Zwelling LA, Kohn KW (1983) Quenching of DNA-platinum II mono-adducts as a possible mechanism of resistance tocis-diamminedichloroplatinum(II) in L1210 cells. Cancer Res 43:3609

    Google Scholar 

  155. Mickisch GH, Kössig J, Keilhauer G, Schlick E, Tschada RK, Alken PM (1990) Effects of calcium antagonists in multidrug resistant primary renal cell carcinomas. Cancer Res 50:3670

    Google Scholar 

  156. Milbrandt JD, Heintz NH, White WC, Rothman SM, Hamlin JL (1981) Methotrexate-resistant Chinese hamster ovary cells have amplified a 135-kilobase-pair region that includes the dihydrofolate reductase gene. Proc Natl Acad Sci USA 78:6043

    Google Scholar 

  157. Miller TP, Grogan TM, Dalton WS, Spier CM, Scheper RJ, Salmon SE (1991) P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. J Clin Oncol 9:17

    Google Scholar 

  158. Mimnaugh EG, Dusre L, Arwell J, Myers JE (1989) Differential oxygen radical susceptibility of Adriamycin-sensitive and-resistant MCF-7 human breast tumor cells. Cancer Res 49:8

    Google Scholar 

  159. Minford JK, Kerrigan D, Michael S, Kohn KW, Pommier Y, Mattern MR, Zwelling RA (1984) Intercalator-dependent DNA-protein crosslinking activity copurifies with a type II topoisomerase from murine leukemia cells. Proc Am Assoc Cancer Res 25:298

    Google Scholar 

  160. Mulkins MA, Heidelberger C (1982) Biochemical characterization of fluoropyrimidine-resistant murine leukemic cell lines. Cancer Res 42:965

    Google Scholar 

  161. Mungikar A, Chitnis M, Gothoskar B (1981) Mixed-function oxidase enzymes in Adriamycin-sensitive and-resistant sublines of P-388 leukemia. Chem Biol Interact 35:119

    Google Scholar 

  162. Murphy MP, Andrews PA, Howell SB (1985) Metallothionein mediated cisplatin and melphalan resistance in human ovarian carcinoma. Proc Am Assoc Cancer Res 26:344

    Google Scholar 

  163. Nelson EM, Tewey KM, Liu LF (1984) Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4′(9-acridinylamino)methane-sulfon-m-aniside. Proc Natl Acad Sci USA 81:1361

    Google Scholar 

  164. Niethammer D, Jackson RC (1975) Changes of molecular properties associated with the development of resistance against methotrexate in human lymphoblastoid cells. Eur J Cancer 11:845

    Google Scholar 

  165. Nunberg JH, Kaufman RJ, Schimke RT, Urlaub G, Chasin LA (1978) Amplified dihydrofolate reductase genes are localised to a homogeneously staining region of a single chromosome in a methotrexate-resistant Chinese hamster ovary cell line. Proc Natl Acad Sci USA 75:5553

    Google Scholar 

  166. Ohnuma T, Lo RJ, Scanlon K, Kamen BA, Ohnoshi T, Wolman SR, Holland JF (1985) Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitro. Cancer Res 45:1815

    Google Scholar 

  167. Ozols RF, Cunnion RE, Klecker RW Jr, Hamilton TC, Ostchega Y, Parrillo JR, Young RC (1987) Verapamil and Adriamycin in the treatment of drug-resistant ovarian cancer patients. J Clin Oncol 5:641

    Google Scholar 

  168. Ozols RF, Louie KG, Plowman J, Behrens BC, Fine RL, Dykes D, Hamilton TC (1987) Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor bearing nude mice by buthionine sulfoxymine depletion of glutathione. Biochem Pharmacol 36:147

    Google Scholar 

  169. Peterson RHF, Myers MB, Spengler BA, Biedler J (1983) Alteration of plasma membrane glycopeptides and gangliosides of Chinese hamster cells accompanying development of resistance to daunomycin and vincristine. Cancer Res 43:222

    Google Scholar 

  170. Plageman PGW, Marz R, Wohlhuether RM (1978) Transport and metabolism of deoxycytidine and 1-β-d-arabinofuranosylcytosine into cultured Novikoff rat hepatoma cells, relationship to phosphorylation, and regulation of triphosphate synthesis. Cancer Res 38:978

    Google Scholar 

  171. Pommier Y, Mattern MR, Schwartz RE, Zwelling LA, Kohn KW (1984) Changes in deoxynucleic acid linking number due to treatment of mammalian cells with the intercalating agent 4′-(9-acridinylamino)-methanesulfon-m-aniside. Biochem 23:2927

    Google Scholar 

  172. Pommier Y, Schwartz RE, Zwelling LA, Kerrigan D, Mattern MR, Charcosset JY, Jacquemin A, Kohn KW (1986) Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors. Cancer Res 46:611

    Google Scholar 

  173. Priest DG, Ledfort BE, Doig MT (1980) Increased thymidylate synthetase in 5-fluorodeoxyuridine-resistant cultured hepatoma cells. Biochem Pharmacol 29:1533

    Google Scholar 

  174. Rader J, Niethammer D, Huennekens FM (1974) Effects of sulfhydryl inhibitors upon transport of folate compounds into L1210 cells. Biochem Pharmacol 23:2057

    Google Scholar 

  175. Ramu A, Sahn T, Glaubiger D (1983) Enhancement of doxoruribicin and vincristine sensitivity in anthracycline-resistant P388 cells. Cancer Treat Rep 67:895

    Google Scholar 

  176. Ramu A, Glaubiger D, Magrath IT, Joshie A (1983) Plasma membrane lipid structural order in doxorubicin-sensitive and-resistant P388 cells. Cancer Res 43:5533

    Google Scholar 

  177. Ramu A, Glaubiger D, Fuks Z (1984) Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues. Cancer Res 44:4392

    Google Scholar 

  178. Redwood WR, Colvin M (1980) Transport of melphalan by sensitive and resistant L1210 cells. Cancer Res 40:1144

    Google Scholar 

  179. Reichard P, Sköld O, Klein G (1959) Possible enzymatic mechanisms for the development of resistance against fluorouracil in ascites tumours. Nature 183:939

    Google Scholar 

  180. Reichard P, Sköld O, Klein G, Révësz L, Magnusson PH (1962) Studies on resistance against 5-fluorouracil: I. Enzymes of the uracil pathway during development of resistance. Cancer Res 22:235

    Google Scholar 

  181. Relle-Somfai S, Suzukake K, Vistica BP, Vistica DT (1984) Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant tol-phenylalaninemustard. Biochem Pharmacol 33:485

    Google Scholar 

  182. Richert N, Akiyama S, Shen DW, Gottesman MM, Pastan I (1985) Multiple drug-resistant human KB carcinoma cells have decreased amounts of a 75 kDa and a 72 kDa glycoprotein. Proc Natl Acad Sci USA 82:2230

    Google Scholar 

  183. Richon VM, Coday NA, Eastman A (1986) Mechanism ofcis-diamminedichloroplatinum(II) resistance in a murine leukemia L1210 cell line. Proc Am Assoc Cancer Res 27:291

    Google Scholar 

  184. Richon VM, Schulte N, Eastman A (1987) Multiple mechanisms of resistance tocis-diamminedichloroplatinum(II) in murine leukemia. Cancer Res 47:2056

    Google Scholar 

  185. Riordan JR, Ling V (1979) Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J Biol Chem 254:12701

    Google Scholar 

  186. Riordan JR, Deuchars K, Kartner N, Alou N, Trent J, Ling V (1958) Amplification of P-glycoprotein genes in multidrug resistant mammalian cell lines. Nature 316:817

    Google Scholar 

  187. Roberts JJ, Crathorn AR, Brent TP (1968) Repair of alkylated DNA in mammalian cells. Nature 218:970

    Google Scholar 

  188. Robertson SM, Ling V, Stanners CP (1984) Co-amplification of double minute chromosomes, multidrug resistance and cell surface P-glycoprotein in DNA mediated transformants of mouse cells. Mol Cell Biol 4:500

    Google Scholar 

  189. Robson CR, Harris AL, Hickson ID (1985) Isolation and characterization of Chinese hamster ovary cell lines sensitive to mitomycin C and bleomycin. Cancer Res 45: 5304

    Google Scholar 

  190. Rogan AM, Hamilton TC, Young RC, Klecker RW Jr, Ozols RF (1984) Reversal of Adriamycin resistance by verapamil in human ovarian cancer. Science 224: 994

    Google Scholar 

  191. Rogers KE, Carr BI, Tökés ZA (1983) Cell surface-mediated cytotoxicity of polymer-bound Adriamycin against drug resistant hepatocytes. Cancer Res 43: 2741

    Google Scholar 

  192. Roninson IB, Abelson HT, Housman DE, Howell N, Varshavsky A (1984) Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells. Nature 309: 626

    Google Scholar 

  193. Roninson IB, Chin JE, Choi K, Gros P, Housman DE, Fojo A, Shen D, Gottesman M, Pastan I (1986) Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 83: 4538

    Google Scholar 

  194. Rosenberg MC, Colvin OM, Griffith OW, Bigner SH, Elion GB, Horton JK, Lilley E, Bigner DB, Friedman HS (1989) Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion. Cancer Res 49: 6917

    Google Scholar 

  195. Rosman M, Williams HE (1973) Leukocyte purine phosphoribosyl-transferases in human leukemias sensitive and resistant to 6-thiopurines. Cancer Res 33: 1202

    Google Scholar 

  196. Rosman M, Lee MH, Creasey WA, Sartorelli AC (1974) Mechanisms of resistance to 6-thiopurines in human leukemia. Cancer Res 34: 1952

    Google Scholar 

  197. Rosowsky A, Lazarus H, Yuan GC, Beltz WR, Mangini L, Abelson HT, Moderst EJ, Frei E (1980) Effects of methotrexate esters and other lipophilic antifolates on methotrexate-resistant human leukemic lymphoblasts. Biochem Pharmacol 29: 648

    Google Scholar 

  198. Rosowsky A, Wright JE, Cucchi CA, Lipke JA, Tantraahki R, Ervin TJ, Frei E (1985) Phenotypic heterogeneity in cultured head and neck squamous cell carcinoma lines with low-level methotrexate resistance. Cancer Res 45: 6205

    Google Scholar 

  199. Rossana C, Rao LG, Johnson LF (1982) Thymidylate synthetase overproduction in 5-fluorodeoxyuridine-resistant mouse fibroblasts. Mol Cell Biol 2: 1118

    Google Scholar 

  200. Roy SN, Horwitz SB (1985) A phosphoglycoprotein associated with taxol resistance in J 774.2 cells. Cancer Res 45: 3856

    Google Scholar 

  201. Saburi Y, Nakagawa M, Ono M, Sakai M, Muramatsu M, Kohno K, Kuwano M (1989) Increased expression of glutathione S-transferase gene incis-diamminedichloroplatinum(II)-resistant variants of a Chinese hamster ovary cell line. Cancer Res 49: 7020

    Google Scholar 

  202. Safa AR, Glover CJ, Sewell JL, Meyers MB, Biedler JL, Felsted RL (1987) Identification of the multidrug-resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. J Biol Chem 262: 7884

    Google Scholar 

  203. Samuels BL, Murray JL, Cohen MB, Safa AR, Sinha BK, Townsend AJ, Beckett MA, Weichselbaum RR (1991) Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance. Cancer Res 51: 521

    Google Scholar 

  204. Sato K, Hieda N (1979) Isolation and characterization of mutant mouse lymphoma cells sensitive to methyl methane sulphonate and X rays. Radiat Res 78: 167

    Google Scholar 

  205. Schabel FM, Trader MW, Laster WR, Wheeler GP, Witt MH (1978) Patterns of resistance and therapeutic synergism among alkylating agents. Antibiot Chemother 23: 200

    Google Scholar 

  206. Schilder RJ, Monks A, Handel LM, Fornace AJ Jr, Ozols RF, Fojo AT, Hamilton TC (1990) Metallothionein gene expression and resistance to cisplatin in human ovarian cancer. Int J Cancer 45: 416

    Google Scholar 

  207. Schimke RT, Kaufman RJ, Alt FW, Kellems RF (1978) Gene amplification and drug resistance in cultured murine cells. Science 202: 1051

    Google Scholar 

  208. Schimke RT, Brown PC, Kaufman RJ, McGrogan M, Slate D (1981) Chromosomal and extrachromosomal localization of amplified dihydrofolate reductase genes in cultured mammalian cells. Cold Spring Harbor Symp Quant Biol 45: 795

    Google Scholar 

  209. Scholar EM, Calabresi EM (1979) Increased activity of alkaline phosphatase in leukemic cells from patients resistant to thiopurines. Biochem Pharmacol 28: 445

    Google Scholar 

  210. Sebti SM, Mignano JE, Jani JP, Sritmatkandada S, Lazo JS (1989) Bleomycin hydrolase: molecular cloning, sequencing and biochemical studies reveal membership in the cysteine proteinase family. Biochemistry 28: 6544

    Google Scholar 

  211. Sebti SM, Jani JP, Mistry JS, Gorelik E, Lazo JS (1991) Metabolic inactivation: a mechanism of human tumor resistance to bleomycin. Cancer Res 51: 227

    Google Scholar 

  212. Shen DW, Cardarelli C, Hwang J, Cornwell M, Richert N, Ishii S, Pastan I, Gottesman MM (1986) Multiple drug resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, Adriamycin, or vinblastine show changes in expression of specific proteins. J Biol Chem 261: 7762

    Google Scholar 

  213. Shen DW, Fojo A, Chin JE, Abelson IB, Richert N, Pastan I, Gottesman MM (1986) Human multidrug-resistant cell lines: increased mdr 1 expression can precede gene amplification. Science 232: 643

    Google Scholar 

  214. Shiomi T, Hieda-Shiomi N, Sato K (1982) A novel mutant of mouse lymphoma cells sensitive to alkylating agents and caffeine. Mutat Res 103: 61

    Google Scholar 

  215. Siegfried JA, Kennedy KA, Sartorelli AC, Tritton TR (1983) Role of membranes in the mechanisms of action of the antineoplastic agent Adriamycin. J Biol Chem 258: 339

    Google Scholar 

  216. Sinha BK, Katki AG, Batist G, Cowan KH, Myers CE (1987) Differential formation of hydroxyl radicals by Adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action. Biochemistry 26: 3776

    Google Scholar 

  217. Sirotnak FM (1980) Correlates of folate analog transport, pharmacokinetics and selective antitumor action. Pharmacol Ther 8: 71

    Google Scholar 

  218. Sirotnak FM (1985) Obligate genetic expression in tumor cells of a fetal membrane property mediating “folate” transport: biological significance and implications for improved therapy of human cancer. Cancer Res 45: 3992

    Google Scholar 

  219. Sirotnak FM, Moccio DM, Kelleher LE, Goutas LJ (1981) Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo. Cancer Res 41: 4447

    Google Scholar 

  220. Sirotnak FM, Goutas LJ, Mines LS (1985) Extent of the requirement for folate transport by L1210 cells for growth and leukemogenesis in vivo. Cancer Res 45: 4732

    Google Scholar 

  221. Sirotnak FM, Goutas LJ, Jacobsen DM, Mines LJ, Barrueco JR, Gaumont Y, Kisliuk RL (1987) Carrier-mediated transport of folate compounds in L1210 cells. Initial rate kinetics and extent of duality of entry routes for folic acid and diastereomers of 5-methyltetrahydrohomofolate in the presence of physiological anions. Biochem Pharmacol 36: 1659

    Google Scholar 

  222. Skovsgaard T (1978) Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells. Cancer Res 38: 1785

    Google Scholar 

  223. Skovsgaard T (1978) Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells. Cancer Res 38: 4722

    Google Scholar 

  224. Skovsgaard T, Friche E (1983) Circumvention of resistance to daunorubicin. In: Hansen HH (ed) Anthracyclines and cancer therapy. Excerpta Medica, Amsterdam, pp 39–48

    Google Scholar 

  225. Slater LM, Murray SL, Wetzel MW (1982) Verapamil restauration in daunorubicin responsiveness in daunorubicin resistant Ehrlich ascites carcinoma. J Clin Invest 70: 1131

    Google Scholar 

  226. Smyth JF, Robins AB, Leese CL (1976) The metabolism of cytosine arabinosine as a predictive test for clinical response for the drug in acute myeloid leukemia. Eur J Cancer 12: 567

    Google Scholar 

  227. Steerenberg PA, Vendrik CPJ, De Jong WH, De Groot G, Fichtinger-Schepman AMJ, Scheefhals APH, Schornagel JH (1988) Resistance and cross-resistance of the IgM immunocytoma in the LOU/M Wsl rat for cisplatin, carboplatin, and iproplatin. Cancer Chemother Pharmacol 22: 51

    Google Scholar 

  228. Steward CD, Burke PJ (1971) Cytidine deaminase and the development of resistance to arabinosyl cytosine. Nat New Biol 223: 109

    Google Scholar 

  229. Sugawara I, Kataoka I, Morishita Y, Hamada H, Tsuruo T, Itoyama S, Mori S (1988) Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 48: 1926

    Google Scholar 

  230. Suzukake K, Petro BJ, Vistica DT (1982) Reduction in glutathione content ofl-PAM resistant L1210 cells confers drug sensitivity. Biochem Pharmacol 31: 121

    Google Scholar 

  231. Suzukake K, Vistica BP, Vistica DT (1983) Dechlorination ofl-phenylalanine mustard by sensitive and resistant tumor cells and its relationship to intracellular glutathione content. Biochem Pharmacol 32: 165

    Google Scholar 

  232. Takeda Y, Nishio K, Sugimoto Y, Kasahara K, Kubo S, Fujiwara Y, Niitani H, Saijo N (1991) Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance. Int J Cancer 48: 931

    Google Scholar 

  233. Tattersall MHN, Ganeshaguru K, Hoffbrand AV (1974) Mechanisms of resistance of human acute leukemia cells to cytosine arabinoside. Br J Haematol 37: 39

    Google Scholar 

  234. Taylor RF, Teague LA, Yesair DW (1981) Drug-binding macromolecular lipids from L1210 leukemia tumors. Cancer Res 41: 4316

    Google Scholar 

  235. Teicher BA, Cucchi CA, Lee JB, Flotow JL, Rosowsky A, Frei E (1986) Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines. Cancer Res 46: 4379

    Google Scholar 

  236. Teicher BA, Holden SA, Kelley MJ, Shea TC, Cucchi CA, Rosowsky A, Henner WD, Frei E (1987) Characterization of a human squamous carcinoma cell line resistant tocis-diammine-dichloroplatinum-II. Cancer Res 47: 388

    Google Scholar 

  237. Tewey KM, Rowe TC, Yang TC, Halligan BD, Liu LF (1984) Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226: 466

    Google Scholar 

  238. Thiebout T, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1987) Cellular localisation of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84: 7735

    Google Scholar 

  239. Thompson LH, Brookman KW, Dillehay LE, Carrano AV, Mazrimas JA, Mooney CL, Minkler JL (1982) A CHO cell strain having hypersensitivity to mutagens, a defect in DNA strand-break repair and an extraordinary baseline frequency of sister chromatid exchange. Mutat Res 95: 427

    Google Scholar 

  240. Tökés ZA, Rogers KE, Rembaum A (1982) Synthesis of Adriamycin-coupled polyglutaraldehyde microspheres and evaluation of their cytostatic activity. Proc Natl Acad Sci USA 79: 2026

    Google Scholar 

  241. Torres-Garcia ST, Cousineau L, Caplan S, Panasci L (1989) Correlation of resistance to nitrogen mustards in chronic lymphocytic leukemia with enhanced removal of melphalan-induced DNA cross-links. Biochem Pharmacol 38: 3122

    Google Scholar 

  242. Trent JM, Buick RN, Olson S, Horns RC, Schimke RT (1984) Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma. J Clin Oncol 2: 8

    Google Scholar 

  243. Tritton TR, Yee G (1983) The anticancer agent Adriamycin can be actively cytotoxic without entering cells. Science 217: 248

    Google Scholar 

  244. Tsuruo T, Iida H, Tsukagoshi S, Sakuray Y (1981) Overcoming of vincristine resistance in P 388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41: 1967

    Google Scholar 

  245. Tsuruo T, Iida H, Tsukagoshi S, Sakuray Y (1982) Increased accumulation of vincristine and Adriamycin in drug resistant P 388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res 42: 4730

    Google Scholar 

  246. Tsuruo T, Iida H, Nagamuma K, Tsukagoshi S, Sakuray Y (1983) Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug. Cancer Res 43: 808

    Google Scholar 

  247. Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakuray Y (1983) Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res 43: 2905

    Google Scholar 

  248. Van der Bliek AM, Van der Velde-Koerts T, Ling V, Borst P (1986) Overexpression and amplification of five genes in a multidrug-resistant Chinese hamster ovary cell line. Mol Cell Biol 6: 1671

    Google Scholar 

  249. Van der Bliek AM, Baas F, Ten Houte-De Lange T, Kooiman PM, Van der Velde-Koerts T, Borst P (1987) The human mdr 3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver. EMBO J 6: 3325

    Google Scholar 

  250. Vendrik CPJ, De Jong WH, Van der Minnen ACE, Fichtinger-Schepman AMJ, Steerenberg PA, Schornagel JH (1990) Resistance of in vitro grown IgM immunocytoma cells tocis-diamminedichloroplatinum(II) (cis-DDP) and cross-resistance to other DNA interacting drugs. Anticancer Res 10: 447

    Google Scholar 

  251. Wang AL, Tew KD (1985) Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards. Cancer Treat Rep 69: 677

    Google Scholar 

  252. Wang Y, Teicher BA, Shea TC, Holden SA, Rosbe KW, Al-Achi A, Henner WD (1989) Cross-resistance and glutathione-S-transferase-π levels among four human melanoma cell lines selected for alkylating agent resistance. Cancer Res 49: 6185

    Google Scholar 

  253. Waud WR, Blount SR (1985) Biochemical studies on resistance to cis-platinum in L1210 leukemia. Proc Am Assoc Cancer Res 26: 260

    Google Scholar 

  254. Webb M, Chain K (1982) Functions of metallothionein. Biochem Pharmacol 31: 137

    Google Scholar 

  255. Wheeler C, Rader R, Kessel D (1982) Membrane alterations associated with progressive Adriamycin resistance. Biochem Pharmacol 31: 2691

    Google Scholar 

  256. Willingham MC, Cornwell MM, Cardarelli CO, Gottesman MM, Pastan I (1986) Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and-sensitive KB cells: effect of verapamil and other drugs. Cancer Res 46: 5941

    Google Scholar 

  257. Yalowich JC, Ross WE (1984) Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitro. Cancer Res 44: 3360

    Google Scholar 

  258. Yalowich JC, Fry DW, Goldman ID (1981) Rapid accumulation of methotrexate polyglutamates in Ehrlich ascites tumor cells in vitro: a marked augmentation by vincristine. Proc Am Assoc Cancer Res 22: 207

    Google Scholar 

  259. Yang L, Rowe TC, Liu LF (1985) Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in Simian virus 40-infected monkey cells. Cancer Res 45: 5872

    Google Scholar 

  260. Yusa K, Tsuruo T (1989) Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites, and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res 49: 5002

    Google Scholar 

  261. Zuckerman JE, Raffin TA, Brown JM, Newman RA, Etiz BB, Sikic BI (1986) In vitro selection and characterization of a bleomycin-resistant subline of B16 melanoma. Cancer Res 46: 1748

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory for Pathology, National Institute of Public Health and Environmental Protection, P. O. Box 1, 3720 BA, Bilthoven, The Netherlands

    C. P. J. Vendrik, J. J. Bergers, W. H. De Jong & P. A. Steerenberg

  2. Oncology Unit, Department of Internal Medicine, University Hospital Utrecht, Utrecht, The Netherlands

    C. P. J. Vendrik

Authors
  1. C. P. J. Vendrik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. J. Bergers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. H. De Jong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. A. Steerenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vendrik, C.P.J., Bergers, J.J., De Jong, W.H. et al. Resistance to cytostatic drugs at the cellular level. Cancer Chemother. Pharmacol. 29, 413–429 (1992). https://doi.org/10.1007/BF00684841

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00684841

Keywords

Search

Navigation